BioSpace News Archive

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”), today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 14,000,000 shares of AIkido’s common stock, at a purchase price of $1.00 per share, in a registered direct offering priced at-the-market under Nasdaq rules.

The Boston Business Journal has named Biopoint Inc. to its exclusive 2020 Fast 50 list, which represent the 50 fastest-growing private companies in Massachusetts..

When the COVID-19 outbreak first reached the U.S., the country’s response to the epidemic was hamstrung by extensive and unnecessary regulations causing a lack of testing capacity.

48Hour Discovery Inc. announced that it has initiated drug discovery projects for therapeutic targets related to COVID-19.

Boston Pharmaceuticals is honored to have been named one of the top ten Health Care and Biopharma companies on Fortune’s 2020 Best Workplaces ranking.